Home Topics FDA

FDA

Supporters of U.S. President Donald Trump react to tear gas during a clash with police officers in front of the U.S. Capitol Building in Washington, U.S., January 6, 2021. REUTERS-Leah Millis

Coronavirus: Concern grows over potential superspreader event during US Capitol riot

Concerns are mounting about the health of lawmakers and other people in the Capitol last week, after the first member to test positive for the Coronavirus (COVID-19) since Wednesday’s chaos, said she believed she was exposed in a crowded hiding place with hundreds of other legislators.

Coronavirus: Prof. Maurice Iwu restates efficacy of herbal medicine

Bioresources Development Group (BDG) chairman, Prof. Maurice Iwu has restated the efficacy of herbal medicine in the treatment of the COVID-19 cases as the virus enters variant stage globally.
Another new variant of the novel coronavirus seems to have emerged in Nigeria, the head of Africa's disease control body said on Thursday, cautioning more investigation was needed.

Virologist: Coronavirus vaccines not 100% solution

Dr. Arthur, speaking in an interview with Berla Mundi on the New Day show on TV3 on December 31, stated that the much awaited vaccines for the COVID-19 pandemic should not be confused with drugs that will cure the virus but rather just a vaccine which is not hundred percent cure-proof for the virus.
FILE PHOTO - Vials with a sticker reading, COVID-19 - Coronavirus vaccine - Injection only and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS-Dado Ruvic-Illustration-File Photo

U.S. gets second coronavirus vaccine

The U.S. Food and Drug Administration (FDA) on Friday approved for emergency use a second coronavirus vaccine produced by American biotechnology company, Moderna.
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

Johnson & Johnson enrolls about 45,000 participants for late-stage coronavirus vaccine trial

Johnson & Johnson said on Thursday it has enrolled about 45,000 participants for the first late-stage trial of its COVID-19 single-dose vaccine candidate and that it expects interim data by late-January.
FILE PHOTO - Vials with a sticker reading, COVID-19 - Coronavirus vaccine - Injection only and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS-Dado Ruvic-Illustration-File Photo

U.S. FDA advisory panel sets stage for Moderna vaccine authorization

A panel of outside advisers to the U.S. Food and Drug Administration on Thursday overwhelmingly endorsed emergency use of Moderna Inc’s coronavirus vaccine, virtually assuring a second option for protecting against COVID-19 for a pandemic ravaged nation.
An independent committee of experts recommended that the Food and Drug Administration authorize the Moderna COVID-19 vaccine for people 18 and older.

Moderna vaccine gets sign-off from US FDA committee

An independent committee of experts recommended that the Food and Drug Administration authorize the Moderna COVID-19 vaccine for people 18 and older. This is the second COVID-19 vaccine to go before the committee — the first, made by Pfizer and BioNTech, was authorized last week.
Former Nigerian lawmaker Dino Melaye has said he will challenge his loss to All Progressives Congress’s Smart Adeyemi in the Kogi West Senatorial district election.

Senator Melaye urges Nigerians not to take coronavirus vaccine

Dino Melaye, a former Nigerian senator, has urged Nigerians not to be vaccinated against the coronavirus, which has killed thousands across the world and almost two thousand people in Nigeria.
FILE PHOTO - Vials with a sticker reading, COVID-19 - Coronavirus vaccine - Injection only and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS-Dado Ruvic-Illustration

Moderna vaccine safe and effective – US experts

The analysis by the Food and Drug Administration’s (FDA) means it could become the second coronavirus vaccine to be allowed in the US.
FILE PHOTO - Vials with a sticker reading, COVID-19 - Coronavirus vaccine - Injection only and a medical syringe are seen in front of a displayed Moderna logo in this illustration taken October 31, 2020. REUTERS-Dado Ruvic-Illustration

Moderna’s coronavirus vaccine clears first U.S. FDA hurdle

Moderna Inc’s COVID-19 vaccine appeared to be set for regulatory authorization this week after U.S. Food and Drug Administration staff members did not raise any major new concerns about it in documents released on Tuesday.
The US public will start receiving the Pfizer-BioNTech coronavirus vaccine from Monday after it was authorised for emergency use, officials say.

EU regulator set to approve Pfizer/BioNTech coronavirus vaccine on December 23

The European Medicines Agency (EMA) is set to approve its first COVID-19 vaccine on Dec. 23, a German government source told Reuters on Tuesday, putting EU countries on track to start to catch up with the United States and Britain, where immunisation campaigns are under way.
US President Donald Trump, on Monday, alleged that some poll watchers were thrown out of vote counting rooms in most states which led to the victory of Joe Biden.

Donald Trump: I’m not scheduled to get coronavirus vaccine

Outgoing U.S. President Donald Trump on Sunday night said he was not scheduled to be vaccinated against the Coronavirus (COVID-19), after a media report indicated he could receive a jab as early as Monday.
Trucks are seen at the Pfizer Global Supply manufacturing plant, amid the coronavirus disease (COVID-19) outbreak, in Portage, Michigan, U.S., December 13, 2020. REUTERS-Rebecca Cook

Historic U.S. vaccine campaign begins with first shipments ‘delivering hope’ to millions

The first shipments of COVID-19 vaccine left on trucks and planes early on Sunday, kicking off a historic effort to stop a surging pandemic that is claiming more than 2,400 lives a day in the United States.
Even as United States have continued to harvest huge numbers of deaths and hospitalization occasioned by novel Coronavirus (Covid-19) infections, hope has come for victims as the first Covid-19 vaccines shipment in American soil have left Kalamazoo factory of one of the world’s drugs manufacturing companies Pfizer.

First US coronavirus vaccine shipment leaves Pfizer Michigan facility

Even as United States have continued to harvest huge numbers of deaths and hospitalization occasioned by novel Coronavirus (Covid-19) infections, hope has come for victims as the first Covid-19 vaccines shipment in American soil have left Kalamazoo factory of one of the world’s drugs manufacturing companies Pfizer.
The US public will start receiving the Pfizer-BioNTech coronavirus vaccine from Monday after it was authorised for emergency use, officials say.

US public to receive Pfizer vaccinations from Monday

The US public will start receiving the Pfizer/BioNTech coronavirus vaccine from Monday after it was authorised for emergency use, officials say.

KAD ICT Hub trains 10,000 Kaduna residents in three years – chief

The KAD ICT Hub, established to bridge the digital gap in Kaduna State, said that it had trained 10,000 residents of the state in different digital skills from inception in 2017 to 2020.
An independent committee of experts recommended Thursday that the Food and Drug Administration authorize the Pfizer and BioNTech COVID-19 vaccine for people over the age of 16. Now, the FDA will decide whether to follow that recommendation.

FDA: Independent committee recommends authorization of coronavirus vaccine

An independent committee of experts recommended Thursday that the Food and Drug Administration authorize the Pfizer and BioNTech COVID-19 vaccine for people over the age of 16. Now, the FDA will decide whether to follow that recommendation. The agency could announce a decision within days. If they do authorize the vaccine, health care workers could begin receiving the shots almost immediately.
Syringes are seen in front of displayed Biontech and Pfizer logos in this illustration taken November 10, 2020. REUTERS-Dado Ruvic-File Photo

Pfizer vaccine data wins backing of US FDA staff

Pfizer Inc has scaled the next hurdle in the race to get its COVID-19 vaccine approved for emergency use after the U.S. Food and Drug Administration (FDA) released documents that raised no new issues about its safety or efficacy.

Recent Stories

Speaking during a press conference in Abuja on Monday, NDLEA Chairman, Buba Marwa, said over 15 million Nigerians abuse drugs nationwide.

NDLEA chair: Over 15 million Nigerians abuse drugs

The National Drug Law Enforcement Agency (NDLEA) has lamented the rate of drug abuse in the country.
Fabinho has insisted that Mohamed Salah is very happy at Liverpool amid speculation over the Liverpool star's future.

Mo Salah: I want to stay at Liverpool as long as I can

The Egypt international, the Premier League's top scorer this season with 13 goals, has a contract until the summer of 2023 and has said he wants to stay and continue to break records with the Reds.

Telegram says it ‘shut down hundreds of public calls for violence’ in US last...

Amid rising political tensions in the United States, Telegram founder Pavel Durov says his chat service has taken down hundreds of public calls for violence, in accordance with the platform’s terms of service.
An FBI warrant logged Jan. 17 identifies Riley June Williams, shown in an undated driver's license photo, as the Pennsylvania resident accused of unlawfully breaching the U.S. Capitol and directing people to House Speaker Nancy Pelosi's office.

FBI: Capitol rioter hoped to sell Nancy Pelosi laptop to Russia

A young woman identified as having taken part in the storming of the US Capitol reportedly stole a laptop belonging to top Democrat Nancy Pelosi and hoped to sell it to a Russian spy agency, according to an FBI criminal complaint.
Former Imo State Governor Rochas Okorocha has urged his supporters to resist further attacks from the government. He said he would no longer tolerate unwarranted assaults on his person and relatives.

2023: Why we are forming new political movement – Senator Okorocha

Okorocha, representing Imo West Senatorial District in the National Assembly, said himself and other progressive-minded politicians were perfecting the plan as a result of the silent agitations and complaints across the country against the current state of the nation.